547 related articles for article (PubMed ID: 14674008)
1. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.
Cuzzocrea S; Mazzon E; Dugo L; Patel NS; Serraino I; Di Paola R; Genovese T; Britti D; De Maio M; Caputi AP; Thiemermann C
Arthritis Rheum; 2003 Dec; 48(12):3544-56. PubMed ID: 14674008
[TBL] [Abstract][Full Text] [Related]
2. CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis.
Mazzon E; Esposito E; Impellizzeri D; DI Paola R; Melani A; Bramanti P; Pedata F; Cuzzocrea S
J Rheumatol; 2011 Oct; 38(10):2119-29. PubMed ID: 21765105
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse.
Cuzzocrea S; Mazzon E; di Paola R; Genovese T; Patel NS; Britti D; de Majo M; Caputi AP; Thiemermann C
Arthritis Rheum; 2005 Mar; 52(3):940-50. PubMed ID: 15751086
[TBL] [Abstract][Full Text] [Related]
4. Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis.
Cuzzocrea S; Mazzon E; Dugo L; Serraino I; Britti D; De Maio M; Caputi AP
Eur Cytokine Netw; 2001; 12(4):568-80. PubMed ID: 11781183
[TBL] [Abstract][Full Text] [Related]
5. Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice.
Impellizzeri D; Esposito E; Mazzon E; Paterniti I; Di Paola R; Morittu VM; Procopio A; Britti D; Cuzzocrea S
J Pharmacol Exp Ther; 2011 Dec; 339(3):859-69. PubMed ID: 21880869
[TBL] [Abstract][Full Text] [Related]
6. Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.
Cuzzocrea S; Mazzon E; Bevilaqua C; Costantino G; Britti D; Mazzullo G; De Sarro A; Caputi AP
Br J Pharmacol; 2000 Dec; 131(7):1399-407. PubMed ID: 11090113
[TBL] [Abstract][Full Text] [Related]
7. Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process.
Smith RJ; Sly LM
J Pharmacol Exp Ther; 1996 Jun; 277(3):1801-13. PubMed ID: 8667252
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis.
Cuzzocrea S; McDonald MC; Mota-Filipe H; Mazzon E; Costantino G; Britti D; Mazzullo G; Caputi AP; Thiemermann C
Arthritis Rheum; 2000 Feb; 43(2):320-8. PubMed ID: 10693871
[TBL] [Abstract][Full Text] [Related]
9. Ethyl pyruvate therapy attenuates experimental severe arthritis caused by type II collagen (CII) in the mouse (CIA).
Di Paola R; Mazzon E; Galuppo M; Esposito E; Bramanti P; Fink MP; Cuzzocrea S
Int J Immunopathol Pharmacol; 2010; 23(4):1087-98. PubMed ID: 21244758
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic.
Salvemini D; Mazzon E; Dugo L; Serraino I; De Sarro A; Caputi AP; Cuzzocrea S
Arthritis Rheum; 2001 Dec; 44(12):2909-21. PubMed ID: 11762952
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse.
Cuzzocrea S; Mazzon E; Di Paola R; Muià C; Crisafulli C; Dugo L; Collin M; Britti D; Caputi AP; Thiemermann C
Clin Immunol; 2006 Jul; 120(1):57-67. PubMed ID: 16631408
[TBL] [Abstract][Full Text] [Related]
12. Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis.
Cuzzocrea S; Mazzon E; Paola RD; Genovese T; Muià C; Caputi AP; Salvemini D
Arthritis Rheum; 2005 Jun; 52(6):1929-40. PubMed ID: 15934059
[TBL] [Abstract][Full Text] [Related]
13. THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis.
Tomita T; Kakiuchi Y; Tsao PS
Arthritis Res Ther; 2006; 8(1):R7. PubMed ID: 16356194
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
15. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Fulia F; Cuzzocrea E; Di Rosa M; Caputi AP; Thiemermann C
Crit Care Med; 2004 Feb; 32(2):457-66. PubMed ID: 14758164
[TBL] [Abstract][Full Text] [Related]
17. Absence of endogenous interleukin-10 enhances the evolution of acute lung injury.
Cuzzocrea S; Mazzon E; Dugo L; Serraino I; Di Paola R; Genovese T; De Sarro A; Caputi AP
Eur Cytokine Netw; 2002; 13(3):285-97. PubMed ID: 12231472
[TBL] [Abstract][Full Text] [Related]
18. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
19. (5R)-5-hydroxytriptolide attenuated collagen-induced arthritis in DBA/1 mice via suppressing interferon-gamma production and its related signaling.
Zhou R; Tang W; Ren YX; He PL; Zhang F; Shi LP; Fu YF; Li YC; Ono S; Fujiwara H; Yang YF; Zuo JP
J Pharmacol Exp Ther; 2006 Jul; 318(1):35-44. PubMed ID: 16574782
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Maffia P; Patel NS; Di Paola R; Ialenti A; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Eur J Pharmacol; 2004 Jan; 483(1):79-93. PubMed ID: 14709329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
